J&J medtech disappoints as medicine unit drives earnings beat

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A J&J’s Imaavy shows positive results in wAIHA trial Hisse Senetleri 0 16
A UBS sees limited upside for some MedTech names despite steady outlook Hisse Senetleri 0 19
A H.C. Wainwright reiterates Sanara MedTech stock rating at buy Hisse Senetleri 0 18
A KeyBanc upgrades Solventum on valuation gap in Medtech Hisse Senetleri 0 34
A Experts can testify about suspected J&J talc products’ cancer link, special master recommends Hisse Senetleri 0 41
A J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award Hisse Senetleri 0 38
A J&J to buy cancer therapy developer Halda Therapeutics for $3.05 billion Hisse Senetleri 0 45

Benzer konular

Üst